PRESS RELEASE
Published May 15, 2023
How
Big is the Women’s Health Market ? :
IMARC
Group’s latest report, titled “Women’s Health Market: Global Industry
Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the
global women’s health market size reached US$
39.32 Billion in 2022. Looking forward, IMARC Group expects the market to reach
US$ 51.65 Billion by 2028, exhibiting a growth rate (CAGR) of 4.33% during
2023-2028.
What
is Women’s Health ? :
Women’s
health refers to the branch of medicine and healthcare that focuses on the
unique health needs and concerns of women throughout their lifespans. It
involves various issues, including reproductive and sexual health, menstrual
cycle management, contraception, menopause, breast health, gynecological
conditions, pregnancy, childbirth, and female-specific cancers. Some common
women’s health issues include painful periods, irregular periods, heavy
bleeding, infertility, sexually transmitted infections (STIs), and cervical
cancer. It also encompasses mental health, addressing the unique psychological
and emotional challenges women may face throughout their lives. Besides,
women’s health helps to enhance overall health in women, reduce the risk of
chronic diseases, improve the physical, mental, and emotional health of women,
and improve health outcomes.
Request
Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/womens-health-market/requestsample
Who
are the key Players Operating in the Industry ? :
The
competitive landscape of the industry has also been examined along with the
profiles of the key players being,
- Abbott Laboratories
- AbbVie Inc
- Agile Therapeutics Inc
- Amgen Inc
- Bayer AG
- Hoffmann-La Roche AG
- Ferring Pharmaceuticals
- FUJIFILM Holdings
Corporation - Hologic Inc
- Lupin Limited
- Novo Nordisk A/S
- Pfizer Inc
What
are the Growth Prospects and Trends in the Women’s
Health Industry ? :
The
growing prevalence of chronic illnesses among women is driving the global
market. Moreover, the rising awareness and education regarding health needs and
the available treatment options are contributing to the growth of the market.
Besides, continual developments of innovative diagnostic tools, medical
devices, and treatment options, such as advanced imaging techniques, minimally
invasive procedures, and personalized medicine, are fuelling the growth of the
market.
Furthermore, governments and healthcare organizations worldwide are
implementing initiatives to improve women’s access to healthcare services,
promote gender equity, and reduce health disparities, thereby creating a
positive market outlook. The market is further driven by changing lifestyles,
rising health consciousness, growing demand for fertility solutions, and
increasing focus on personalized medicine.
Ask
Analyst for Instant Discount and Download Full Report with TOC & List of
Figure: https://www.imarcgroup.com/womens-health-market
Key
Market Segmentation:
Age
Group Type Insights:
- 50 Years and
Above - Postmenopausal
Osteoporosis - Endometriosis and
Uterine Fibroids - Menopause
- Others
Application
Insights:
- Contraceptives
- Osteoporosis
- Menopause
- Infertility
- Others
Distribution
Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup
by Region:
- North America (United
States, Canada) - Europe (Germany,
France, United Kingdom, Italy, Spain, Others) - Asia Pacific (China,
Japan, India, Australia, Indonesia, Korea, Others) - Latin America (Brazil,
Mexico, Others) - Middle East and Africa
(United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key
Highlights of the Report:
- Market Performance
(2017-2022) - Market Outlook
(2023-2028) - Porter’s Five Forces
Analysis - Market Drivers and
Success Factors - SWOT Analysis
- Value Chain
- Comprehensive Mapping
of the Competitive Landscape
About
Us:
IMARC
Group is a leading market research company that offers management strategy and
market research worldwide. We partner with clients in all sectors and regions
to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact
us:
IMARC
Group
134
N 4th St. Brooklyn, NY 11249, USA
Email:
[email protected]
Tel
No:(D) +91 120 433 0800
Americas:-
+1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia:
+91-120-433-0800, +91-120-433-0800
—————————————————-
Source link